Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/14791
|
| Title: | Phospholipid remodeling and its derivatives are associated with COVID-19 severity |
| Authors: | Wei, J;Liu, X;Xiao, W;Lu, J;Guan, L;Fang, Z;Chen, J;Sun, B;Cai, Z;Sun, X;Chen, HL;Zhong, N;Liu, Z;Yang, J;Xiao, X;Huang, SK |
| Contributors: | National Institute of Environmental Health Sciences |
| Abstract: | BACKGROUND: Timely medical interventions in severe cases of COVID-19 and better understanding of the pathogenesis are essential for reducing the mortality, but early classification of severe cases and its progression is challenging. OBJECTIVE: To investigate the levels of circulating phospholipid metabolites and their relationship with the severity of COVID-19 and the potential role of phospholipids in the progression of the disease. METHODS: In this study, we performed non-targeted lipidomic analysis of plasma samples (n=150) collected from COVID-19 patients (N=46) with three levels of severity, healthy individuals and subjects with metabolic diseases. RESULTS: Results showed that phospholipid metabolism was significantly altered in COVID-19 patients. A panel of phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) and of phosphatidylethanolamine (PE) and lysophosphatidylethanolamine (LPE) ratios were significantly correlated with the severity of COVID-19, in which 16 phospholipid ratios were shown to distinguish severe patients from mild cases and healthy controls, and 9 of which were at variance with those in subjects with metabolic diseases. In particular, relatively lower ratios of circulating (PC16:1/22:6)/LPC16:1 and (PE18:1/22:6)/LPE18:1 were the most indicative of severe COVID-19. The elevation of levels of LPC16:1 and LPE18:1 contributed to the changes of related lipid ratios. An exploratory functional study of LPC16:1 and LPE18:1 demonstrated their ability in causing membrane perturbation, increased intracellular calcium, cytokines, and apoptosis in cellular models. CONCLUSION: These results demonstrate significant Lands cycle remodeling in patients with severe COVID-19, and suggest the potential utility of selective phospholipids with functional consequences in evaluating COVID-19 severity and its pathogenesis. |
| Date: | 2023-05 |
| Relation: | Journal of Allergy and Clinical Immunology. 2023 May;151(5):1259-1268. |
| Link to: | http://dx.doi.org/10.1016/j.jaci.2022.11.032 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0091-6749&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000997773400001 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85148856257 |
| Appears in Collections: | [黃嘯谷] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB36736798.pdf | | 7353Kb | Adobe PDF | 171 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
